ALNY

#336
Alnylam Pharmaceuticals, Inc.
339.41 USD
+1.92%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
339.41
339.41
年范围
225.84
495.55
日变化
+1.92%
每月变动
+9.06%
6个月变化
-27.66%
年变化
+41.50%
前一天收盘价
333.00
开盘价
339.41
买价
卖价
最低价
339.41
High
339.41
交易量
197
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 45.01 B
  • Employee 2 500
  • Founded 2002
  • CEO Yvonne Greenstreet
  • Website www.alnylam.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BFGNJ5
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
170.67
市销率
14.42

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

新闻